secwatch / observer
8-K filed April 24, 2023, 7:59 PM ET ticker ONCO CIK 0001782107
other material confidence high sentiment positive materiality 0.60

Blue Water Vaccines changes name to Blue Water Biotech after ENTADFI acquisition

Onconetix, Inc.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Onconetix, Inc.: Amended Second Amended and Restated Certificate of Incorporation to change corporate name from 'Blue Water Vaccines Inc.' to 'Blue Water Biotech, Inc.' (effective 2023-04-21).

Change
charter amendment
Effective
2023-04-21
Exact text from the filing
On April 21, 2023, Blue Water Biotech, Inc., a Delaware corporation (the “Company”), filed an amendment to its Second Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware to change its corporate name from “Blue Water Vaccines Inc.” to “Blue Water Biotech, Inc.” (the “Name Change Amendment”). The name change was effective as of April 21, 2023.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Onconetix, Inc.: Amended bylaws to reflect corporate name change to Blue Water Biotech, Inc (effective 2023-04-21).

Change
bylaw amendment
Effective
2023-04-21
Exact text from the filing
In connection with the name change, the Company amended the Company’s bylaws to reflect the corporate name Blue Water Biotech, Inc., also effective on April 21, 2023. No other changes were made to the bylaws.
View on SEC.gov

75 governance changes filed in the last 30 days. Browse all governance changes →

Onconetix, Inc. filing history →

Source: SEC EDGAR
accession 0001213900-23-031827
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.